Azenta, Inc. - Common Stock (AZTA)

18.25
+0.60 (3.40%)
NASDAQ· Last Trade: May 20th, 12:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close17.65
Open18.13
Bid18.24
Ask18.26
Day's Range17.70 - 18.72
52 Week Range15.93 - 41.73
Volume631,526
Market Cap984.02M
PE Ratio (TTM)-13.83
EPS (TTM)-1.3
Dividend & YieldN/A (N/A)
1 Month Average Volume1,423,217

Chart

About Azenta, Inc. - Common Stock (AZTA)

Azenta, Inc. is a leading provider of life sciences solutions, focusing on enabling advancements in research and development through its innovative technologies and services. The company specializes in genomic solutions, including sample storage, processing, and logistics, aimed at supporting biobanking and accelerating the discovery of new therapies. With a commitment to enhancing global health, Azenta's offerings cater to the needs of pharmaceutical and biotechnology companies, academic institutions, and research organizations, ultimately striving to improve the efficiency and effectiveness of life sciences research. Read More

News & Press Releases

Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
Looking back on drug development inputs & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Azenta (NASDAQ:AZTA) a...
Via StockStory · May 19, 2026
Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. (NASDAQ:AZTA) on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Azenta (AZTA) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 19, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 19, 2026
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · May 18, 2026
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or “the Company”) (NASDAQ: AZTA) for violations of the securities laws.
By Schall Law · Via GlobeNewswire · May 18, 2026
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · May 13, 2026
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of the federal securities laws.
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of federal securities laws.
Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions
Azenta’s first quarter was marked by operational challenges and a more cautious demand environment, which contributed to results well below market expectatio...
Via StockStory · May 13, 2026
1 Russell 2000 Stock Worth Your Attention and 2 We Question
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Via StockStory · May 13, 2026
AZENTA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Azenta (AZTA) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2026
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) on behalf of investors concerning the Company’s possible violations of federal securities laws.
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · May 11, 2026
AZENTA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via Business Wire · May 8, 2026
Azenta (AZTA) Q2 2026 Earnings Call Transcriptfool.com
Azenta (AZTA) Q2 2026 Earnings Call Transcript
Via The Motley Fool · May 6, 2026
Azenta (AZTA) Reports Earnings Tomorrow: What To Expect
Life sciences company Azenta (NASDAQ:AZTA) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. Azenta beat ...
Via StockStory · May 4, 2026
2 Cash-Heavy Stocks on Our Buy List and 1 We Turn Down
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...
Via StockStory · April 23, 2026
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Via StockStory · April 22, 2026
3 Stocks Under $50 We’re Skeptical Of
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Via StockStory · April 17, 2026
Curious about the stocks that are showing activity after the closing bell on Thursday?chartmill.com
Via Chartmill · April 16, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · April 1, 2026
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via StockStory · March 27, 2026
Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...
Via StockStory · March 22, 2026
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · March 20, 2026
3 Unprofitable Stocks That Concern Us
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via StockStory · March 19, 2026